immunotherapy as a game-changer in multimodal management of lung cancer
Published 3 years ago • 1.1K plays • Length 1:11:16Download video MP4
Download video MP3
Similar videos
-
1:02:05
adjuvant egfr-targeted therapy as a game changer in multimodal nsclc management
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
36:55
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
18:58
pd-l1 testing by immunohistochemistry
-
4:17
how does lung cancer affect the body?
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
1:03:14
changing the game for es-sclc with immunotherapy and multidisciplinary collaboration
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:03:31
elevating care in resectable stage i-iii nsclc
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
3:46
understanding immunotherapy for lung cancer
-
1:08:56
toward better outcomes in sclc: immunotherapy has changed the game, but where do we go next?
-
1:08:00
has immunotherapy brought us to an inflection point in the management of stage i-iii nsclc?
-
1:11:21
maximizing the potential of immunotherapy in unresectable stage iii nsclc
-
17:30
immunotherapy in lung cancer: panacea vs. reality?
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents